Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series

BACKGROUND: Herein, we describe the use of systemic immunotherapy for both locally advanced and metastatic conjunctival melanoma. Current treatments for advanced conjunctival melanoma typically result in poor local control leading to disfiguring orbital exenteration surgery. Locoregional spread of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Finger, Paul T., Pavlick, Anna C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434860/
https://www.ncbi.nlm.nih.gov/pubmed/30909967
http://dx.doi.org/10.1186/s40425-019-0555-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434860/
https://www.ncbi.nlm.nih.gov/pubmed/30909967
http://dx.doi.org/10.1186/s40425-019-0555-7

Ejemplares similares